SignatureFD’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $923K | Sell |
1,758
-383
| -18% | -$201K | 0.02% | 370 |
|
|
2025
Q1 | $1.36M | Buy |
2,141
+113
| +6% | +$71.7K | 0.03% | 261 |
|
|
2024
Q4 | $1.44M | Sell |
2,028
-337
| -14% | -$240K | 0.03% | 230 |
|
|
2024
Q3 | $2.49M | Buy |
2,365
+23
| +1% | +$24.2K | 0.05% | 143 |
|
|
2024
Q2 | $2.46M | Buy |
2,342
+92
| +4% | +$96.7K | 0.05% | 135 |
|
|
2024
Q1 | $2.17M | Buy |
2,250
+124
| +6% | +$119K | 0.05% | 154 |
|
|
2023
Q4 | $1.87M | Buy |
2,126
+54
| +3% | +$47.4K | 0.04% | 167 |
|
|
2023
Q3 | $1.71M | Buy |
2,072
+156
| +8% | +$128K | 0.04% | 157 |
|
|
2023
Q2 | $1.38M | Sell |
1,916
-71
| -4% | -$51K | 0.04% | 194 |
|
|
2023
Q1 | $1.63M | Buy |
1,987
+125
| +7% | +$103K | 0.04% | 151 |
|
|
2022
Q4 | $1.34M | Buy |
1,862
+93
| +5% | +$67.1K | 0.04% | 173 |
|
|
2022
Q3 | $1.22M | Buy |
1,769
+248
| +16% | +$171K | 0.04% | 152 |
|
|
2022
Q2 | $899K | Sell |
1,521
-163
| -10% | -$96.3K | 0.03% | 214 |
|
|
2022
Q1 | $1.18M | Buy |
1,684
+149
| +10% | +$104K | 0.04% | 185 |
|
|
2021
Q4 | $969K | Buy |
1,535
+214
| +16% | +$135K | 0.03% | 220 |
|
|
2021
Q3 | $799K | Buy |
1,321
+152
| +13% | +$91.9K | 0.03% | 239 |
|
|
2021
Q2 | $653K | Buy |
1,169
+437
| +60% | +$244K | 0.03% | 277 |
|
|
2021
Q1 | $346K | Sell |
732
-177
| -19% | -$83.7K | 0.02% | 403 |
|
|
2020
Q4 | $439K | Buy |
909
+46
| +5% | +$22.2K | 0.02% | 299 |
|
|
2020
Q3 | $483K | Buy |
863
+46
| +6% | +$25.7K | 0.03% | 242 |
|
|
2020
Q2 | $510K | Buy |
817
+246
| +43% | +$154K | 0.03% | 213 |
|
|
2020
Q1 | $279K | Buy |
571
+282
| +98% | +$138K | 0.02% | 316 |
|
|
2019
Q4 | $109K | Buy |
289
+85
| +42% | +$32.1K | 0.01% | 670 |
|
|
2019
Q3 | $57K | Sell |
204
-80
| -28% | -$22.4K | ﹤0.01% | 867 |
|
|
2019
Q2 | $89K | Sell |
284
-201
| -41% | -$63K | 0.01% | 673 |
|
|
2019
Q1 | $199K | Sell |
485
-531
| -52% | -$218K | 0.02% | 392 |
|
|
2018
Q4 | $379K | Buy |
1,016
+131
| +15% | +$48.9K | 0.04% | 207 |
|
|
2018
Q3 | $358K | Buy |
885
+527
| +147% | +$213K | 0.04% | 268 |
|
|
2018
Q2 | $124K | Buy |
358
+198
| +124% | +$68.6K | 0.01% | 539 |
|
|
2018
Q1 | $55K | Buy |
+160
| New | +$55K | 0.01% | 704 |
|
|
2016
Q4 | – | Sell |
-77
| Closed | -$31K | – | 985 |
|
|
2016
Q3 | $31K | Buy |
77
+5
| +7% | +$2.01K | ﹤0.01% | 671 |
|
|
2016
Q2 | $25K | Buy |
72
+6
| +9% | +$2.08K | ﹤0.01% | 662 |
|
|
2016
Q1 | $24K | Buy |
66
+15
| +29% | +$5.46K | ﹤0.01% | 615 |
|
|
2015
Q4 | $28K | Buy |
51
+21
| +70% | +$11.5K | 0.01% | 495 |
|
|
2015
Q3 | $14K | Buy |
30
+26
| +650% | +$12.1K | ﹤0.01% | 611 |
|
|
2015
Q2 | $2K | Buy |
+4
| New | +$2K | ﹤0.01% | 896 |
|